GUIDELINE FOR FLOW CYTOMETRIC IMMUNOPHENOTYPING - A REPORT FROM THE NATIONAL-INSTITUTE-OF-ALLERGY-AND-INFECTIOUS-DISEASES, DIVISION OF AIDS
GUIDELINE FOR FLOW CYTOMETRIC IMMUNOPHENOTYPING - A REPORT FROM THE NATIONAL-INSTITUTE-OF-ALLERGY-AND-INFECTIOUS-DISEASES, DIVISION OF AIDS
复制标题
DOI:
10.1002/cyto.990140703
复制
发表时间:
1993-10-01
期刊:
影响因子:
--
通讯作者:
KAGAN, J
中科院分区:
文献类型:
--
作者:
CALVELLI, T;DENNY, TN;KAGAN, J
Progressive and selective depletion of CD4-positive T lymphocytes is a hallmark of HIV infection and AIDS. Decreases in CD4-positive T cells are associated with increased risk for opportunistic infection and disease progression in HIV-infected individuals. In HIV infection, the CD4 T-cell count is the most commonly utilized laboratory measure for clinical prognosis, therapeutic monitoring, and entry criteria for clinical trials. Currently, the enumeration of CD4 T cells involves three distinct measurements: the white blood count (WBC), the lymphocyte differential (percent lymphocytes), and the percentage of T lymphocytes that are CD4 positive (CD4 percent). The WBC and percent lymphocytes are routinely measured on whole blood samples using an automated hematology instrument. The CD4 percent is measured on whole blood by flow cytometric immunophenotyping. The sample is reacted with fluorochromelabeled monoclonal antibodies that are specific for cellsurface antigens (eg, CD4). When analyzed on a flow cytometer, cells that have bound the labeled antibody can be quantified on the basis of their fluorescence emission. Simultaneously, lymphocytes are resolved from other white blood cells (granulocytes, monocytes) based on size and granularity using light scatter properties. The resulting CD4% is used to calculate the CD4 cell number (ie, absolute CD4, CD4 count) by the formula: